Abstract Non-aqueous emulsification solvent evaporation method was used to prepare sustained release diclofenac sodium (DS) particles having high DS content while minimizing formulation time. Microparticles were evaluated on the basis of batch yield, encapsulation efficiency, particle size and particle size distribution, effect of surfactant concentration, phase volume ratio, different internal phases, and Eudragit RSPO or Eudragit RLPO used singly or in a 1:1 combination. The 1:1 combination of acetone and isopropanol as the internal phase produced microparticles with higher batch yield and higher encapsulation efficiency. A combination of 1: 1 Eudragit RSPO and Eudragit RLPO formed sustained release microparticles having higher encapsulation efficiency than microparticles formulated using individual polymers. The release of DS was faster from formulations prepared using 3% surfactant concentration than those prepared using 1% or 2% surfactant concentration. Formulations prepared using 60 ml and 80 ml external phase formed microparticles with higher encapsulation efficiency and slower DS release than those prepared using 100 ml external phase. With internal phase volume kept constant at 40 ml, the volume of external phase affected formulation time taking about 1.5 h when the external phase was 60 ml and about 3.5 h when the external phase volume was 100 ml.
Corresponding Authors: P. L. Madan, St. John’s University, College of Pharmacy, Queens, New York 11439, USA.
Tel: +1-718-9906242; Fax: +1-718-9901877
Email: madanp@stjohns.edu
Cite this article:
Mansi P. Shah,
Pooja K. Patel,
S. Lin etc
.Formulation variables affecting release of diclofenac sodium from eudragit-loaded microparticles[J] AJPS, 2011,V6(6): 241-250
Tuncay M, Calis S, Kas HS, et al. In vitro and in vivo evaluation of diclofenac sodium loaded albumin microspheres. J Microencapsul. 2000, 17: 145-155.
[2]
Biju SS, Saisivam S, Rajan NSMG, et al. Dual coated erodible microcapsules for modified release of diclofenac sodium. Eur J Pharm Biopharm. 2004, 58: 61-67.
[3]
Gohel MC, Amin AF. Formulation optimization of controlled release diclofenac sodium microspheres using factorial design. J. Control Release. 1998, 51: 115-122.
[4]
Manjunatha KM, Ramana MV, Satyanarayana D. Design and evaluation of diclofenac sodium controlled drug delivery systems. Indian J Pharm Sci. 2007, 69: 384-389.
[5]
Sajeev C, Vinay G, Archna R, et al. Oral controlled release formulation of diclofenac sodium by microencapsulation with ethyl cellulose. J Microencapsul. 2002, 19: 753-760..
[6]
Haznedar S, Dortunç B. Preparation and in vitro evaluation of Eudragit microspheres containing acetazolamide. Int J Pharm. 2004, 269: 131-140.
[7]
Khamanga SE, Parfitt N, Nyamuzhiwa T, et al. The evaluation of eudragit microcapsules manufactured by solvent evpaoration using USP apparatus 1. Dissolut Tech. 2009. 16: 15-22.
[8]
Kristmundsdóttir T, Gudmundsson ÓS, Ingvarsdóttir K. Release of diltiazem from Eudragit microparticles prepared by spray-drying. Int J Pharm. 1996, 137: 159-165.
[9]
Wu P, Huang Y, Chang J, et al. Design and evaluation of sustained release microspheres of potassium chloride prepared by Eudragit®. Eur J Pharm Sci. 2003, 19: 115-122.
[10]
Krishnamachari Y, Madan P, Lin S. Development of pH and time dependent oral microparticles to optimize budesonide delivery to ileum and colon. Int J Pharm. 2007, 338: 238-247.
[11]
Kim BK, Hwang SJ, Park JB, et al. Preparation and characterization of drug-loaded polymethacrylate microspheres by an emulsion solvent evaporation method. J Microencapsul. 2002. 19: 811-822.
[12]
Basu SK, Adhiyaman R. Preparation and characterization of nitrendipine loaded Eudragit RL 100 microspheres prepared by an emulsion-solvent evaporation method. Trop J Pharm Res. 2008, 7: 1033-1041.
[13]
Nilkumhang S, Basit AW. The robustness and flexibility of an emulsion solvent evaporation method to prepare pH-responsive microparticles. Int J Pharm. 2009, 377: 135-141.
[14]
Tarcha PJ. Diffusion controlled systems: polymeric microcapsules (Ch 1) in polymers for controlled drug delivery, CRC Press, USA, 1991, 1-14
[15]
Rosca ID, Watari F, Uo M. Microparticle formation and its mechanism in single and double emulsion solvent evaporation. J Control Release. 2004, 99: 271-280.
[16]
Das MK, Rao K. Microencapsulation of Zidovudine by double emulsion solvent diffusion technique using ethylcellulose. Indian J Pharm Sci. 2007, 69: 244-250
[17]
Imam ME, Bernkop-Schnürch Andreas. Controlled drug delivery systems based on thiolated chitosan microspheres. Drug Dev Ind Pharm. 2005, 31: 557-565.
[18]
Kyo M, Hyon S-Ikada Y. Effects of preparation conditions of cisplatin-loaded microspheres on the in vitro release. J Control Release. 1995, 35: 73-82.
[19]
Sadeghi F, Eidi M, Ansaripoor N, et al. Preparation and evaluation of microcapsules containing diclofenac sodium and Eudragit RS or RL as oral sustained release multiparticulate delivery system. Pharm Sci. 2008, 1: 9-18.
[20]
Vogel AI, Experimental methods in: anonymous a text-book of practical organic chemistry including qualitative organic analysis, 3rd Ed., Longman Group Limited, Great Britain, 1956, 62-78.
[21]
Carli F, Capone G, Colombo I, et al. Surface and transport properties of acrylic polymers influencing drug release from porous matrices. Int J Pharm. 1984, 21: 317-329.
[22]
Malamataris S, Avgerinos A. Controlled release indomethacin microspheres prepared by using an emulsion solvent-diffusion technique. Int J Pharm. 1990, 62: 105-111.
[23]
Khalil Khalil E, Sallam A. Interaction of two diclofenac acid salts with copolymers of ammoniomethacrylate: effect of additives and release profiles. Drug Dev Ind Pharm. 1999, 25: 419-427.
[24]
Chang R, Hsiao C. Eudragit RL and RS pseudolatices: properties and performance in pharmaceutical coating as a controlled release membrane for theophylline pellets. Drug Dev Ind Pharm. 1989, 15: 187-196.
[25]
Perumal D. Microencapsulation of ibuprofen and Eudragit RS 100 by the emulsion solvent diffusion technique. Int J Pharm. 2001, 218: 1-7.
[26]
Weiland-Berghausen S, Schote U, Frey M, et al. Comparison of microencapsulation techniques for water-soluble drugs nitenpyram and clomipramine HCl. J Control Release. 2002, 85: 35-43.
[27]
Jones DS, Pearce KJ. An investigation of the effects of some process variables on the microencapsulation of propranolol hydrochloride by the solvent evaporation method. Int J Pharm. 1995, 118: 199-205.
2011, Vol. 6 
